Ceat (500878) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
20 Jan, 2026Executive summary
Consolidated revenue for Q3 FY25-26 reached Rs. 4,157 crore, up 26% year-over-year, with strong volume growth across all segments and EBITDA margin at 13.7%.
Standalone revenue grew 20.1% year-over-year to Rs. 3,957 crore, with EBITDA margin at 14.08%.
Net profit for Q3 stood at Rs. 155 crore, up 60% year-over-year, but down sequentially due to a provision for new labour codes.
Replacement, OEM, and international businesses all posted robust growth, with replacement segment benefiting from GST rate reduction and channel restocking.
Board approved Rs. 1,314 crore CapEx for Chennai plant to add 3.5 million passenger car tire capacity by H2 FY2028.
Financial highlights
Consolidated EBITDA for Q3 at Rs. 568 crore (13.7% margin), up 317 basis points year-over-year.
Standalone net profit at Rs. 191.6 crore, up from Rs. 95.97 crore last year, but slightly lower sequentially due to Rs. 57.81 crore provision for new labour codes.
Gross margin for Q3 was 39.9%, down 109 basis points sequentially but up 310 basis points year-over-year.
Finance cost increased by Rs. 18 crore due to higher average debt; total finance cost at Rs. 105 crore.
CapEx outflow for Q3 was Rs. 254 crore; cumulative spend at Rs. 673 crore YTD, excluding Camso intangibles.
Outlook and guidance
Management expects positive momentum to continue, with margin headwinds of 1%-1.5% in Q4 due to currency depreciation and higher natural rubber prices.
Replacement segment expected to sustain high single-digit growth into FY2027.
Camso margins to normalize to double digits from Q4, with further improvement as transition completes over next 3-5 quarters.
CapEx guidance for FY2026 remains at Rs. 1,000 crore, with future annual CapEx likely to rise to Rs. 1,100-1,200 crore.
Growth in the PCUV category is expected, with capacity expansion planned to meet future demand.
Latest events from Ceat
- Acquisition adds premium OHT products, global reach, and 750+ SKUs, boosting growth and margins.500878
M&A Announcement3 Feb 2026 - Q1 FY25 revenue up 8.8% YoY; EBITDA margin down, but PAT and exports grew; ESG progress noted.500878
Q1 24/253 Feb 2026 - Record revenue with margin contraction and lower net profit amid rising costs and higher debt.500878
Q2 24/2519 Jan 2026 - Revenue up 11.6% YoY, but margins and profit fell; major capex and acquisition plans underway.500878
Q3 24/2510 Jan 2026 - $225M deal secures global reach, premiumization, and margin growth by FY 2028.500878
M&A Announcement31 Dec 2025 - Q4 FY25 revenue up 14.3% YoY to INR 3,420.6 crore, EBITDA margin at 11.5%.500878
Q4 24/253 Dec 2025 - Q2 FY26 revenue up 14.2% YoY, Camso integrated, margins expanded, ESG and GST cuts drove demand.500878
Q2 25/2620 Oct 2025 - Q1 FY26 revenue rose 10.5% YoY to Rs. 3,529.4 crore, but margins contracted on higher costs.500878
Q1 25/2626 Aug 2025